Patent details

Basic Information

Publication number:

EP2704798

PCT Application Number:

US2012036072

Type:

European Patent Granted for LU

Legal Status:

In force

Application number:

EP127210938

PCT Publication Number:

WO2012151248

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

FORMULATION FOR ANTI- ALPHA4BETA7 ANTIBODY

French Title of Invention:

FORMULATION POUR UN ANTICORPS ANTI- ALPHA4BÊTA7

German Title of Invention:

FORMULIERUNG FÜR ANTI-ALPHA4BETA7-ANTIKÖRPER

SPC Number:

Dates

Filing date:

02/05/2012

Grant date:

12/07/2017

EP Publication Date:

12/03/2014

PCT Publication Date:

08/11/2012

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

12/07/2017

EP B1 Publication Date:

12/07/2017

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

Expiration date:

02/05/2032

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

13/10/2025

 

 

Name:

MILLENNIUM PHARMACEUTICALS, INC.

Address:

35 Landsdowne St.,, Cambridge, Massachusetts,, United States (US)

History of Owners

From:

14/06/2023

To:

13/10/2025

Name:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Address:

1-1, Doshomachi 4-chome Chuo-ku, 540-8645, Osaka, Japan (JP)

From:

12/07/2017

To:

14/06/2023

Name:

Millennium Pharmaceuticals, Inc.

Address:

40 Landsdowne Street, Cambridge, MA 02139, United States (US)

Agent

Name:

DENNEMEYER & ASSOCIATES S.A. PATENT DEPARTMENT

From:

11/10/2017

Address:

PO Box 1502, 1015, LUXEMBOURG, Luxembourg (LU)

To:

Inventor

1

Name:

BROWN, Jason

Address:

United States (US)

2

Name:

SCHOLZ, Catherine

Address:

United States (US)

3

Name:

TRUONG, Nobel T.

Address:

United States (US)

4

Name:

DILUZIO, Willow

Address:

United States (US)

5

Name:

VARGA, Csanad M.

Address:

United States (US)

6

Name:

FOX, Irving H.

Address:

United States (US)

7

Name:

PALANIAPPAN, Vaithianathan

Address:

United States (US)

Priority

1

Priority Number:

201161481533 P

Priority Date:

02/05/2011

Priority Country:

United States (US)

2

Priority Number:

201161550545 P

Priority Date:

24/10/2011

Priority Country:

United States (US)

3

Priority Number:

201261585859 P

Priority Date:

12/01/2012

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/395; A61P 1/00; C07K 16/28;

Publication

Bulletin

1

Bulletin Heading:

VB2

Bulletin edition number:

2020/02

Publication date:

13/01/2020

Description:

Section J : Applications for patents or supplementary protection certificates having been restored (art. 40 of the law) Patents or supplementary protection certificates having been restored (art. 70 of the law)

2

Bulletin Heading:

CO

Bulletin edition number:

2023/08

Publication date:

03/07/2023

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

3

Bulletin Heading:

CO

Bulletin edition number:

2025/12

Publication date:

07/11/2025

Description:

Section M : Transfers of property (Art. 53 of the law), change of name and/or address

European Patent Bulletin

1

Issue number:

201728

Publication date:

12/07/2017

Description:

Grant (B1)

2

Issue number:

201952

Publication date:

25/12/2019

Description:

Opposition rejected; Patent maintained as granted

3

Issue number:

201733

Publication date:

16/08/2017

Description:

Application number/publication number of the divisional application (Art. 76) changed

Deed

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20230000280A

Date Registered:

14/06/2023

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Dennemeyer & Associates S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

TAKEDA PHARMACEUTICAL COMPANY LIMITED

Address:

1-1, Doshomachi 4-chome Chuo-ku, 540-8645, Osaka, Japan (JP)

Removed Pledgee

Name:

Address:

Change of owner(s)

Change Kind/ Decision Type:

Change of ownership

Deed Number:

RC20250000365A

Date Registered:

13/10/2025

Licence Effective Date:

Licence Expiration Date:

Scope of Licence:

Deed Filer:

Dennemeyer & Associates S.A.

Journal Edition Number:

Text:

Country Code:

Updated Licence Number:

Terminated Licence Number:

Added Owner(s)

Name:

MILLENNIUM PHARMACEUTICALS, INC.

Address:

35 Landsdowne St.,, Cambridge, Massachusetts,, United States (US)

Removed Pledgee

Name:

Address:

Annual Fees

Annual Fee Due Date:

01/06/2026

Annual Fee Number:

15

Annual Fee Amount:

213 Euro

Expected Payer:

Last Annual Fee Payment Date:

23/04/2025

Last Annual Fee Paid Number:

14

Last Annual Fee Paid Amount:

198 Euro

Payer:

ANAQUA SERVICES (ANC. SGA2)

Filing date	Document type	Number of pages
14/06/2023	Request For Change	6
14/06/2023	Outgoing Correspondence	1
12/10/2017	Outgoing Correspondence	1
13/10/2025	Request For Change	16
14/10/2025	Outgoing Correspondence	1
11/10/2017	Power Of Attorney	1